Sanara MedTech Inc. (SMTI) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin as a Percentage of Net Revenue | 93.00 percent | FY2026-Q1 |
| Net Revenue Year-Over-Year Growth | 19.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 4.3M | FY2026-Q1 |
| Distributors with Selling Agreements | 450.00 | FY2026-Q1 |
| Hospitals and Ambulatory Surgery Centers Contracted or Approved to Sell Products | 4K | FY2026-Q1 |
| Net Revenue (Expected Range High) | 27.7M | FY2025-Q4 |
| Net Revenue (Expected Range Low) | 27.2M | FY2025-Q4 |
| Year-Over-Year Net Revenue Growth (Expected Range High) | 5.00 percent | FY2025-Q4 |
| Year-Over-Year Net Revenue Growth (Expected Range Low) | 3.00 percent | FY2025-Q4 |
| Scenera Surgical Segment Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 4.7M | FY2025-Q2 |
| Tissue Health Plus Segment Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | -2.1M | FY2025-Q2 |
Back to SMTI overview · SMTI earnings · SMTI holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.